Lactation is critical to infant short-term and long-term health and protects mothers from breast cancer, ovarian cancer and type 2 diabetes mellitus. The mammary gland is a dynamic organ, regulated by the coordinated actions of reproductive and metabolic hormones. These hormones promote gland development from puberty onwards and induce the formation of a branched, epithelial, milk-secreting organ by the end of pregnancy. Progesterone withdrawal following placental delivery initiates lactation, which is maintained by increased pituitary secretion of prolactin and oxytocin, and stimulated by infant suckling. After weaning, local cytokine production and decreased prolactin secretion trigger large-scale mammary cell loss, leading to gland involution. Here, we review advances in the molecular endocrinology of mammary gland development and milk synthesis. We discuss the hormonal functions of the mammary gland, including parathyroid hormone-related peptide secretion that stimulates maternal calcium mobilization for milk synthesis. We also consider the hormonal composition of human milk and its associated effects on infant health and development. Finally, we highlight endocrine and metabolic diseases that cause lactation insufficiency, for example, monogenic disorders of prolactin and prolactin receptor mutations, maternal obesity and diabetes mellitus, interventions during labour and delivery, and exposure to endocrine-disrupting chemicals such as polyfluoroalkyl substances in consumer products and other oestrogenic compounds.
Reproductive and metabolic hormones coordinate the transformation of the mammary gland from a rudimental ductal structure at the onset of puberty into a milk-secreting organ by the end of pregnancy.
Lactation onset is mediated by a combination of progesterone withdrawal, circulating and mammary gland-derived prolactin, and glucocorticoids; delayed lactation onset is a major cause of early breastfeeding cessation.
Established lactation requires prolactin and oxytocin for milk synthesis and let-down and involves mammary autocrine and paracrine mechanisms triggered by breast emptying; these local mechanisms remain to be elucidated.
The mammary gland is an endocrine organ that secretes hormones into the maternal circulation and milk; hormones in milk influence infant development, body composition and the microbiome.
Lactation insufficiency is caused by genetic and acquired endocrine disturbances; maternal factors with potential endocrine effects on lactation include primiparity, obesity, preterm birth, Caesarean section and retained placental fragments.
Endocrine-disrupting chemicals are environmental pollutants that might affect lactation by altering hormone secretion or mammary gland hormone responsiveness; epidemiological studies highlight potential population-wide effects on breastfeeding.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Victora, C. G. et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387, 475–490 (2016).
Sankar, M. J. et al. Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Paediatr. 104, 3–13 (2015).
Gunderson, E. P. et al. Lactation duration and progression to diabetes in women across the childbearing years: the 30-year CARDIA study. JAMA Intern. Med. 178, 328–337 (2018).
Kotsopoulos, J. et al. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecol. Oncol. 159, 820–826 (2020).
Bach, K. et al. Differentiation dynamics of mammary epithelial cells revealed by single-cell RNA sequencing. Nat. Commun. 8, 2128 (2017).
Fleming, J. M. et al. Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biol. 9, 46 (2008).
Khan, Y. S. & Sajjad, H. Anatomy, thorax, mammary gland. StatPearls https://www.ncbi.nlm.nih.gov/books/NBK547666/ (2021).
Schedin, P. & Keely, P. J. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb. Perspect. Biol. 3, a003228 (2011).
Brenot, A., Hutson, I. & Harris, C. Epithelial-adipocyte interactions are required for mammary gland development, but not for milk production or fertility. Dev. Biol. 458, 153–163 (2020).
Zhao, C. et al. Stromal Gli2 activity coordinates a niche signaling program for mammary epithelial stem cells. Science 356, eaal3485 (2017).
Scheele, C. L. et al. Identity and dynamics of mammary stem cells during branching morphogenesis. Nature 542, 313–317 (2017).
Sternlicht, M. D. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 8, 201 (2006).
Buchmann, B. et al. Mechanical plasticity of collagen directs branch elongation in human mammary gland organoids. Nat. Commun. 12, 2759 (2021).
Akhtar, N. & Streuli, C. H. An integrin-ILK-microtubule network orients cell polarity and lumen formation in glandular epithelium. Nat. Cell Biol. 15, 17–27 (2013).
Howard, B. A. & Gusterson, B. A. Human breast development. J. Mammary Gland. Biol. Neoplasia 5, 119–137 (2000).
McNally, S. & Stein, T. Overview of mammary gland development: a comparison of mouse and human. Methods Mol. Biol. 1501, 1–17 (2017).
Richert, M. M., Schwertfeger, K. L., Ryder, J. W. & Anderson, S. M. An atlas of mouse mammary gland development. J. Mammary Gland. Biol. Neoplasia 5, 227–241 (2000).
Oakes, S. R., Hilton, H. N. & Ormandy, C. J. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 8, 207 (2006).
Wang, Q. A. & Scherer, P. E. Remodeling of murine mammary adipose tissue during pregnancy, lactation, and involution. J. Mammary Gland. Biol. Neoplasia 24, 207–212 (2019).
Lemay, D. G. et al. RNA sequencing of the human milk fat layer transcriptome reveals distinct gene expression profiles at three stages of lactation. PLoS One 8, e67531 (2013).
Rios, A. C. et al. Essential role for a novel population of binucleated mammary epithelial cells in lactation. Nat. Commun. 7, 11400 (2016).
Neville, M. C. et al. Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am. J. Clin. Nutr. 54, 81–92 (1991).
Anderson, S. M., Rudolph, M. C., McManaman, J. L. & Neville, M. C. Key stages in mammary gland development. Secretory activation in the mammary gland: it’s not just about milk protein synthesis! Breast Cancer Res. 9, 204 (2007).
Nyquist, S. K. et al. Cellular and transcriptional diversity over the course of human lactation. Proc. Natl Acad. Sci. USA 119, e2121720119 (2022).
Li, M. et al. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl Acad. Sci. USA 94, 3425–3430 (1997).
Watson, C. J. Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res. 8, 203 (2006).
Nissan, N., Furman-Haran, E., Shapiro-Feinberg, M., Grobgeld, D. & Degani, H. Monitoring in-vivo the mammary gland microstructure during morphogenesis from lactation to post-weaning using diffusion tensor MRI. J. Mammary Gland. Biol. Neoplasia 22, 193–202 (2017).
Ruan, W. & Kleinberg, D. L. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140, 5075–5081 (1999).
Vandenberg, L. N. et al. The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue-level of organization. J. Steroid Biochem. Mol. Biol. 101, 263–274 (2006).
Asselin-Labat, M. L. et al. Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798–802 (2010).
Loladze, A. V. et al. Epithelial-specific and stage-specific functions of insulin-like growth factor-I during postnatal mammary development. Endocrinology 147, 5412–5423 (2006).
Ruan, W., Monaco, M. E. & Kleinberg, D. L. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146, 1170–1178 (2005).
Zinser, G., Packman, K. & Welsh, J. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129, 3067–3076 (2002).
Johnson, A. L., Zinser, G. M. & Waltz, S. E. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. Am. J. Physiol. Endocrinol. Metab. 307, E674–E685 (2014).
Yamaji, D., Kang, K., Robinson, G. W. & Hennighausen, L. Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. Nucleic Acids Res. 41, 1622–1636 (2013).
Hu, Y., Ding, Y., Yang, M. & Xiang, Z. Serum prolactin levels across pregnancy and the establishment of reference intervals. Clin. Chem. Lab. Med. 56, 838–842 (2018).
Cox, D. B., Kent, J. C., Casey, T. M., Owens, R. A. & Hartmann, P. E. Breast growth and the urinary excretion of lactose during human pregnancy and early lactation: endocrine relationships. Exp. Physiol. 84, 421–434 (1999).
Brisken, C. et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 210, 96–106 (1999).
Ormandy, C. J. et al. Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog. Horm. Res. 58, 297–323 (2003).
Pang, W. W. & Hartmann, P. E. Initiation of human lactation: secretory differentiation and secretory activation. J. Mammary Gland. Biol. Neoplasia 12, 211–221 (2007).
Bernard, V., Young, J. & Binart, N. Prolactin — a pleiotropic factor in health and disease. Nat. Rev. Endocrinol. 15, 356–365 (2019).
Woodside, B. Prolactin and the hyperphagia of lactation. Physiol. Behav. 91, 375–382 (2007).
Augustine, R. A. et al. Prolactin regulation of oxytocin neurone activity in pregnancy and lactation. J. Physiol. 595, 3591–3605 (2017).
Joshi, P. A. et al. Progesterone induces adult mammary stem cell expansion. Nature 465, 803–807 (2010).
Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J. & Conneely, O. M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl Acad. Sci. USA 100, 9744–9749 (2003).
Beleut, M. et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc. Natl Acad. Sci. USA 107, 2989–2994 (2010).
Rajaram, R. D. et al. Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. EMBO J. 34, 641–652 (2015).
Horigan, K. C. et al. Hormone interactions confer specific proliferative and histomorphogenic responses in the porcine mammary gland. Domest. Anim. Endocrinol. 37, 124–138 (2009).
Lain, A. R., Creighton, C. J. & Conneely, O. M. Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis. Mol. Endocrinol. 27, 1743–1761 (2013).
Yamaji, D. et al. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev. 23, 2382–2387 (2009).
Feng, Y., Manka, D., Wagner, K. U. & Khan, S. A. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc. Natl Acad. Sci. USA 104, 14718–14723 (2007).
Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201–209 (2007).
Oakes, S. R. et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 22, 581–586 (2008).
Lee, H. J. et al. Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development 140, 1397–1401 (2013).
Cattini, P. A., Jin, Y., Jarmasz, J. S., Noorjahan, N. & Bock, M. E. Obesity and regulation of human placental lactogen production in pregnancy. J. Neuroendocrinol. 32, e12859 (2020).
Herman, A. et al. Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen. J. Biol. Chem. 275, 6295–6301 (2000).
Thomas, E. et al. Receptor activator of NF-kappaB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium. Stem Cell 30, 1255–1264 (2012).
Gaede, P., Trolle, D. & Pedersen, H. Extremely low placental lactogen hormone (hPL) values in an otherwise uneventful pregnancy preceding delivery of a normal baby. Acta Obstet. Gynecol. Scand. 57, 203–209 (1978).
Neville, M. C. et al. The insulin receptor plays an important role in secretory differentiation in the mammary gland. Am. J. Physiol. Endocrinol. Metab. 305, E1103–E1114 (2013).
Wintermantel, T. M., Bock, D., Fleig, V., Greiner, E. F. & Schutz, G. The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Mol. Endocrinol. 19, 340–349 (2005).
Mills, E. S. & Topper, Y. J. Some ultrastructural effects of insulin, hydrocortisone, and prolactin on mammary gland explants. J. Cell Biol. 44, 310–328 (1970).
Sornapudi, T. R. et al. Comprehensive profiling of transcriptional networks specific for lactogenic differentiation of HC11 mammary epithelial stem-like cells. Sci. Rep. 8, 11777 (2018).
Zinser, G. M. & Welsh, J. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol. Endocrinol. 18, 2208–2223 (2004).
Buser, A. C. et al. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol. Endocrinol. 21, 106–125 (2007).
Nguyen, D. A., Parlow, A. F. & Neville, M. C. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J. Endocrinol. 170, 347–356 (2001).
Boss, M., Gardner, H. & Hartmann, P. Normal human lactation: closing the gap. F1000Res 7, F1000 Faculty Rev-801 (2018).
Naylor, M. J. et al. Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol. Endocrinol. 19, 1868–1883 (2005).
Chen, C. C. et al. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes. Dev. 26, 2154–2168 (2012).
Boxer, R. B. et al. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab. 4, 475–490 (2006).
Failor, K. L., Desyatnikov, Y., Finger, L. A. & Firestone, G. L. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells. Mol. Endocrinol. 21, 2403–2415 (2007).
Casey, T. M. & Plaut, K. The role of glucocorticoids in secretory activation and milk secretion, a historical perspective. J. Mammary Gland. Biol. Neoplasia 12, 293–304 (2007).
Crowley, W. R. Neuroendocrine regulation of lactation and milk production. Compr. Physiol. 5, 255–291 (2015).
McNeilly, A. S., Robinson, I. C., Houston, M. J. & Howie, P. W. Release of oxytocin and prolactin in response to suckling. BMJ 286, 257–259 (1983).
Stevenson, A. J. et al. Multiscale imaging of basal cell dynamics in the functionally mature mammary gland. Proc. Natl Acad. Sci. USA 117, 26822–26832 (2020).
Mather, I. H., Masedunskas, A., Chen, Y. & Weigert, R. Symposium review: intravital imaging of the lactating mammary gland in live mice reveals novel aspects of milk-lipid secretion. J. Dairy Sci. 102, 2760–2782 (2019).
Diaz, S. et al. Circadian variation of basal plasma prolactin, prolactin response to suckling, and length of amenorrhea in nursing women. J. Clin. Endocrinol. Metab. 68, 946–955 (1989).
Cox, D. B., Owens, R. A. & Hartmann, P. E. Blood and milk prolactin and the rate of milk synthesis in women. Exp. Physiol. 81, 1007–1020 (1996).
Daly, S. E., Kent, J. C., Owens, R. A. & Hartmann, P. E. Frequency and degree of milk removal and the short-term control of human milk synthesis. Exp. Physiol. 81, 861–875 (1996).
Grinman, D. Y. et al. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development. Breast Cancer Res. 24, 30 (2022).
Stewart, T. A. et al. Mammary mechanobiology-investigating roles for mechanically activated ion channels in lactation and involution. J. Cell Sci. 134, jcs.248849 (2021).
Weaver, S. R. & Hernandez, L. L. Autocrine-paracrine regulation of the mammary gland. J. Dairy Sci. 99, 842–853 (2016).
Gunn, A. J. et al. Growth hormone increases breast milk volumes in mothers of preterm infants. Pediatrics 98, 279–282 (1996).
Motil, K. J. et al. Insulin, cortisol and thyroid hormones modulate maternal protein status and milk production and composition in humans. J. Nutr. 124, 1248–1257 (1994).
Capuco, A. V., Kahl, S., Jack, L. J., Bishop, J. O. & Wallace, H. Prolactin and growth hormone stimulation of lactation in mice requires thyroid hormones. Proc. Soc. Exp. Biol. Med. 221, 345–351 (1999).
Campo Verde Arbocco, F., Persia, F. A., Hapon, M. B. & Jahn, G. A. Hypothyroidism decreases JAK/STAT signaling pathway in lactating rat mammary gland. Mol. Cell Endocrinol. 450, 14–23 (2017).
Kritikou, E. A. et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 130, 3459–3468 (2003).
Nguyen, A. V. & Pollard, J. W. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127, 3107–3118 (2000).
Sargeant, T. J. et al. Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization. Nat. Cell Biol. 16, 1057–1068 (2014).
Rieanrakwong, D. et al. Prolactin suppression of gonadotropin-releasing hormone initiation of mammary gland involution in female rats. Endocrinology 157, 2750–2758 (2016).
Bertucci, P. Y., Quaglino, A., Pozzi, A. G., Kordon, E. C. & Pecci, A. Glucocorticoid-induced impairment of mammary gland involution is associated with STAT5 and STAT3 signaling modulation. Endocrinology 151, 5730–5740 (2010).
Krebs, N. F., Reidinger, C. J., Robertson, A. D. & Brenner, M. Bone mineral density changes during lactation: maternal, dietary, and biochemical correlates. Am. J. Clin. Nutr. 65, 1738–1746 (1997).
Lim, C. L. et al. Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism. Elife 9, e57274 (2020).
Radhakrishnan, A. et al. A pathway map of prolactin signaling. J. Cell Commun. Signal. 6, 169–173 (2012).
Rudolph, M. C., Russell, T. D., Webb, P., Neville, M. C. & Anderson, S. M. Prolactin-mediated regulation of lipid biosynthesis genes in vivo in the lactating mammary epithelial cell. Am. J. Physiol. Endocrinol. Metab. 300, E1059–E1068 (2011).
Shin, H. Y., Hennighausen, L. & Yoo, K. H. STAT5-driven enhancers tightly control temporal expression of mammary-specific genes. J. Mammary Gland. Biol. Neoplasia 24, 61–71 (2019).
Liu, F. et al. Prolactin/Jak2 directs apical/basal polarization and luminal linage maturation of mammary epithelial cells through regulation of the Erk1/2 pathway. Stem Cell Res. 15, 376–383 (2015).
Liu, X. et al. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179–186 (1997).
Ormandy, C. J. et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167–178 (1997).
Wagner, K. U. et al. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol. Cell Biol. 24, 5510–5520 (2004).
Bridgewater, R. E., Streuli, C. H. & Caswell, P. T. Extracellular matrix promotes clathrin-dependent endocytosis of prolactin and STAT5 activation in differentiating mammary epithelial cells. Sci. Rep. 7, 4572 (2017).
Rooney, N., Wang, P., Brennan, K., Gilmore, A. P. & Streuli, C. H. The integrin-mediated ILK-Parvin-alphaPix signaling axis controls differentiation in mammary epithelial cells. J. Cell Physiol. 231, 2408–2417 (2016).
Akhtar, N. & Streuli, C. H. Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J. Cell Biol. 173, 781–793 (2006).
Watkin, H. et al. Lactation failure in Src knockout mice is due to impaired secretory activation. BMC Dev. Biol. 8, 6 (2008).
Kitayama, M. et al. A novel nectin-mediated cell adhesion apparatus that is implicated in prolactin receptor signaling for mammary gland development. J. Biol. Chem. 291, 5817–5831 (2016).
Mapes, J. et al. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy. PLoS Genet. 13, e1006654 (2017).
Liao, Y. & Du, W. An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice. J. Biol. Chem. 293, 3156–3167 (2018).
Harris, J. et al. Socs2 and elf5 mediate prolactin-induced mammary gland development. Mol. Endocrinol. 20, 1177–1187 (2006).
Lindeman, G. J. et al. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev. 15, 1631–1636 (2001).
Jinagal, S. L. et al. Prolactin-induced AMPK stabilizes alveologenesis and lactogenesis through regulation of STAT5 signaling. bioRxiv https://doi.org/10.1101/2022.02.15.480514 (2022).
Tarulli, G. A., Laven-Law, G., Shakya, R., Tilley, W. D. & Hickey, T. E. Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation. J. Mammary Gland. Biol. Neoplasia 20, 75–91 (2015).
Cagnet, S. et al. Oestrogen receptor alpha AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium. Nat. Commun. 9, 4723 (2018).
Gagniac, L. et al. Membrane expression of the estrogen receptor ERalpha is required for intercellular communications in the mammary epithelium. Development 147, dev182303 (2020).
Kariagina, A., Aupperlee, M. D. & Haslam, S. Z. Progesterone receptor isoforms and proliferation in the rat mammary gland during development. Endocrinology 148, 2723–2736 (2007).
Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L. & Thakker, R. V. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat. Rev. Endocrinol. 15, 33–51 (2018).
VanHouten, J. N. et al. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J. Clin. Invest. 112, 1429–1436 (2003).
Lotinun, S. et al. Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression. J. Clin. Invest. 129, 3058–3071 (2019).
VanHouten, J. et al. The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J. Clin. Invest. 113, 598–608 (2004).
Mamillapalli, R. et al. Mammary-specific ablation of the calcium-sensing receptor during lactation alters maternal calcium metabolism, milk calcium transport, and neonatal calcium accrual. Endocrinology 154, 3031–3042 (2013).
Mamillapalli, R., VanHouten, J., Zawalich, W. & Wysolmerski, J. Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J. Biol. Chem. 283, 24435–24447 (2008).
VanHouten, J. N., Neville, M. C. & Wysolmerski, J. J. The calcium-sensing receptor regulates plasma membrane calcium adenosine triphosphatase isoform 2 activity in mammary epithelial cells: a mechanism for calcium-regulated calcium transport into milk. Endocrinology 148, 5943–5954 (2007).
Uemura, H. et al. Regulatory factors on parathyroid hormone-related peptide production by primary culture of lactating rat mammary gland. Horm. Metab. Res. 37, 463–467 (2005).
Matsuda, M. et al. Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev. Cell 6, 193–203 (2004).
Hernandez, L. L., Gregerson, K. A. & Horseman, N. D. Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. Am. J. Physiol. Endocrinol. Metab. 302, E1009–E1015 (2012).
Kovacs, C. S. & Chik, C. L. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J. Clin. Endocrinol. Metab. 80, 3036–3042 (1995).
Chan, D. et al. Adiponectin, leptin and insulin in breast milk: associations with maternal characteristics and infant body composition in the first year of life. Int. J. Obes. 42, 36–43 (2018).
Cheema, A. S. et al. Human milk lactose, insulin, and glucose relative to infant body composition during exclusive breastfeeding. Nutrients 13, 3724 (2021).
Fields, D. A. et al. Associations between human breast milk hormones and adipocytokines and infant growth and body composition in the first 6 months of life. Pediatr. Obes. 12, 78–85 (2017).
Lemas, D. J. et al. Alterations in human milk leptin and insulin are associated with early changes in the infant intestinal microbiome. Am. J. Clin. Nutr. 103, 1291–1300 (2016).
Schneider-Worthington, C. R. et al. Associations among maternal adiposity, insulin, and adipokines in circulation and human milk. J. Hum. Lact. 37, 714–722 (2021).
Fields, D. A. & Demerath, E. W. Relationship of insulin, glucose, leptin, IL-6 and TNF-alpha in human breast milk with infant growth and body composition. Pediatr. Obes. 7, 304–312 (2012).
Joung, K. E., Martin, C. R., Cherkerzian, S., Kellogg, M. & Belfort, M. B. Human milk hormone intake in the first month of life and physical growth outcomes in preterm infants. J. Clin. Endocrinol. Metab. 106, 1793–1803 (2021).
Eriksson, U., Duc, G., Froesch, E. R. & Zapf, J. Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum. Biochem. Biophys. Res. Commun. 196, 267–273 (1993).
Donovan, S. M., Hintz, R. L. & Rosenfeld, R. G. Investigation into the potential physiological sources of rat milk IGF-I and IGF-binding proteins. J. Endocrinol. 145, 569–578 (1995).
Galante, L. et al. Growth factor concentrations in human milk are associated with infant weight and BMI from birth to 5 years. Front. Nutr. 7, 110 (2020).
Galante, L. et al. Sexually dimorphic associations between maternal factors and human milk hormonal concentrations. Nutrients 12, 152 (2020).
Scheja, L. & Heeren, J. The endocrine function of adipose tissues in health and cardiometabolic disease. Nat. Rev. Endocrinol. 15, 507–524 (2019).
Gridneva, Z. et al. Human milk adiponectin and leptin and infant body composition over the first 12 months of lactation. Nutrients 10, 1125 (2018).
Sanchez, J. et al. Leptin orally supplied to neonate rats is directly uptaken by the immature stomach and may regulate short-term feeding. Endocrinology 146, 2575–2582 (2005).
Wolinski, J., Biernat, M., Guilloteau, P., Westrom, B. R. & Zabielski, R. Exogenous leptin controls the development of the small intestine in neonatal piglets. J. Endocrinol. 177, 215–222 (2003).
Cross, N. A., Hillman, L. S. & Forte, L. R. The effects of calcium supplementation, duration of lactation, and time of day on concentrations of parathyroid hormone-related protein in human milk: a pilot study. J. Hum. Lact. 14, 111–117 (1998).
Lubetzky, R., Weisman, Y., Dollberg, S., Herman, L. & Mandel, D. Parathyroid hormone-related protein in preterm human milk. Breastfeed. Med. 5, 67–69 (2010).
Tov, A. B. et al. Changes in serum parathyroid hormone-related protein in breastfed preterm infants. Breastfeed. Med. 7, 50–53 (2012).
Liu, C. et al. Parathyroid hormone-related protein (1–40) enhances calcium uptake in rat enterocytes through PTHR1 receptor and protein kinase calpha/beta signaling. Cell Physiol. Biochem. 51, 1695–1709 (2018).
Hollanders, J. J., Heijboer, A. C., van der Voorn, B., Rotteveel, J. & Finken, M. J. J. Nutritional programming by glucocorticoids in breast milk: targets, mechanisms and possible implications. Best Pract. Res. Clin. Endocrinol. Metab. 31, 397–408 (2017).
Pundir, S. et al. Human milk glucocorticoid levels are associated with infant adiposity and head circumference over the first year of life. Front. Nutr. 7, 166 (2020).
Dorr, H. G. et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J. Clin. Endocrinol. Metab. 68, 863–868 (1989).
Pundir, S. et al. Variation of human milk glucocorticoids over 24 hour period. J. Mammary Gland. Biol. Neoplasia 22, 85–92 (2017).
Romijn, M. et al. The association between maternal stress and glucocorticoid rhythmicity in human milk. Nutrients 13, 1608 (2021).
Hollanders, J. J. et al. Biphasic glucocorticoid rhythm in one-month-old infants: reflection of a developing HPA-Axis? J. Clin. Endocrinol. Metab. 105, e544–e554 (2020).
Lee, S. & Kelleher, S. L. Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology. Am. J. Physiol. Endocrinol. Metab. 311, E405–E422 (2016).
Neifert, M. et al. The influence of breast surgery, breast appearance, and pregnancy-induced breast changes on lactation sufficiency as measured by infant weight gain. Birth 17, 31–38 (1990).
Iwama, S., Welt, C. K., Romero, C. J., Radovick, S. & Caturegli, P. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J. Clin. Endocrinol. Metab. 98, 3920–3925 (2013).
Moriwaki, M. & Welt, C. K. PRL mutation causing alactogenesis: insights into prolactin structure and function relationships. J. Clin. Endocrinol. Metab. 106, e3021–e3026 (2021).
Littlejohn, M. D. et al. Functionally reciprocal mutations of the prolactin signalling pathway define hairy and slick cattle. Nat. Commun. 5, 5861 (2014).
Kobayashi, T., Usui, H., Tanaka, H. & Shozu, M. Variant prolactin receptor in agalactia and hyperprolactinemia. N. Engl. J. Med. 379, 2230–2236 (2018).
Newey, P. J. et al. Mutant prolactin receptor and familial hyperprolactinemia. N. Engl. J. Med. 369, 2012–2020 (2013).
Brownell, E., Howard, C. R., Lawrence, R. A. & Dozier, A. M. Delayed onset lactogenesis II predicts the cessation of any or exclusive breastfeeding. J. Pediatr. 161, 608–614 (2012).
Dewey, K. G., Nommsen-Rivers, L. A., Heinig, M. J. & Cohen, R. J. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics 112, 607–619 (2003).
Ramiandrasoa, C. et al. Delayed diagnosis of Sheehan’s syndrome in a developed country: a retrospective cohort study. Eur. J. Endocrinol. 169, 431–438 (2013).
Marasco, L., Marmet, C. & Shell, E. Polycystic ovary syndrome: a connection to insufficient milk supply? J. Hum. Lact. 16, 143–148 (2000).
Vanky, E. et al. Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo. BJOG 119, 1403–1409 (2012).
Sievers, E., Haase, S., Oldigs, H. D. & Schaub, J. The impact of peripartum factors on the onset and duration of lactation. Biol. Neonate 83, 246–252 (2003).
Dos Santos, C. O., Dolzhenko, E., Hodges, E., Smith, A. D. & Hannon, G. J. An epigenetic memory of pregnancy in the mouse mammary gland. Cell Rep. 11, 1102–1109 (2015).
Hill, P. D., Aldag, J. C., Chatterton, R. T. & Zinaman, M. Comparison of milk output between mothers of preterm and term infants: the first 6 weeks after birth. J. Hum. Lact. 21, 22–30 (2005).
Parker, L. A. et al. Indicators of secretory activation in mothers of preterm very low birth weight infants. J. Hum. Lact. 37, 581–592 (2021).
Preusting, I., Brumley, J., Odibo, L., Spatz, D. L. & Louis, J. M. Obesity as a predictor of delayed lactogenesis II. J. Hum. Lact. 33, 684–691 (2017).
Buonfiglio, D. C. et al. Obesity impairs lactation performance in mice by inducing prolactin resistance. Sci. Rep. 6, 22421 (2016).
Neubauer, S. H. et al. Delayed lactogenesis in women with insulin-dependent diabetes mellitus. Am. J. Clin. Nutr. 58, 54–60 (1993).
Joshi, J. V., Bhandarkar, S. D., Chadha, M., Balaiah, D. & Shah, R. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J. Postgrad. Med. 39, 137–141 (1993).
Campo Verde Arbocco, F. et al. Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs. Mol. Cell Endocrinol. 419, 18–28 (2016).
Henderson, J. J., Hartmann, P. E., Moss, T. J., Doherty, D. A. & Newnham, J. P. Disrupted secretory activation of the mammary gland after antenatal glucocorticoid treatment in sheep. Reproduction 136, 649–655 (2008).
Henderson, J. J., Newnham, J. P., Simmer, K. & Hartmann, P. E. Effects of antenatal corticosteroids on urinary markers of the initiation of lactation in pregnant women. Breastfeed. Med. 4, 201–206 (2009).
Jonas, W. et al. Effects of intrapartum oxytocin administration and epidural analgesia on the concentration of plasma oxytocin and prolactin, in response to suckling during the second day postpartum. Breastfeed. Med. 4, 71–82 (2009).
Nissen, E. et al. Different patterns of oxytocin, prolactin but not cortisol release during breastfeeding in women delivered by caesarean section or by the vaginal route. Early Hum. Dev. 45, 103–118 (1996).
Neifert, M. R., McDonough, S. L. & Neville, M. C. Failure of lactogenesis associated with placental retention. Am. J. Obstet. Gynecol. 140, 477–478 (1981).
Zoeller, R. T. et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology 153, 4097–4110 (2012).
Vandenberg, L. N. & Turgeon, J. L. Endocrine disrupting chemicals: understanding what matters. Adv. Pharmacol. 92, xiii–xxiv (2021).
Eckstrum, K. S., Weis, K. E., Baur, N. G., Yoshihara, Y. & Raetzman, L. T. Icam5 Expression exhibits sex differences in the neonatal pituitary and is regulated by estradiol and bisphenol A. Endocrinology 157, 1408–1420 (2016).
Moran, T. B., Brannick, K. E. & Raetzman, L. T. Aryl-hydrocarbon receptor activity modulates prolactin expression in the pituitary. Toxicol. Appl. Pharmacol. 265, 139–145 (2012).
Vandenberg, L. N. Endocrine disrupting chemicals and the mammary gland. Adv. Pharmacol. 92, 237–277 (2021).
Vorderstrasse, B. A., Fenton, S. E., Bohn, A. A., Cundiff, J. A. & Lawrence, B. P. A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol. Sci. 78, 248–257 (2004).
Ohtake, F. et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545–550 (2003).
White, S. S. et al. Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Env. Health Perspect. 119, 1070–1076 (2011).
White, S. S. et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol. Sci. 96, 133–144 (2007).
Catanese, M. C., Suvorov, A. & Vandenberg, L. N. Beyond a means of exposure: a new view of the mother in toxicology research. Toxicol. Res. 4, 592–612 (2015).
LaPlante, C. D., Catanese, M. C., Bansal, R. & Vandenberg, L. N. Bisphenol S alters the lactating mammary gland and nursing behaviors in mice exposed during pregnancy and lactation. Endocrinology 158, 3448–3461 (2017).
Benninghoff, A. D. et al. Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicol. Sci. 120, 42–58 (2011).
Fei, C., McLaughlin, J. K., Lipworth, L. & Olsen, J. Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding. Scand. J. Work Environ. Health 36, 413–421 (2010).
Romano, M. E. et al. Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding. Environ. Res. 149, 239–246 (2016).
Timmermann, C. A. G. et al. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances. Reprod. Toxicol. 68, 164–170 (2017).
Timmermann, C. A. G. et al. Pregnancy exposure to perfluoroalkyl substances, prolactin concentrations and breastfeeding in the Odense Child Cohort. J. Clin. Endocrinol. Metab. 107, e631–e642 (2022).
Criswell, R., Crawford, K. A., Bucinca, H. & Romano, M. E. Endocrine-disrupting chemicals and breastfeeding duration: a review. Curr. Opin. Endocrinol. Diabetes Obes. 27, 388–395 (2020).
Fromme, H. et al. Polychlorinated dioxins and dibenzofurans (PCDD/F), polybrominated dioxins and dibenzofurans (PBDD/F), polychlorinated biphenyls (PCB), polybrominated diphenyl ethers (PBDE), and per- and polyfluoroalkyl substances (PFAS) in German breast milk samples (LUPE 8). Sci. Total. Environ. 825, 154066 (2022).
Martin Carli, J. F. et al. Single cell RNA sequencing of human milk-derived cells reveals sub-populations of mammary epithelial cells with molecular signatures of progenitor and mature states: a novel, non-invasive framework for investigating human lactation physiology. J. Mammary Gland. Biol. Neoplasia 25, 367–387 (2020).
Twigger, A. J. & Khaled, W. T. Mammary gland development from a single cell ‘omics view. Semin. Cell Dev. Biol. 114, 171–185 (2021).
Neville, M. C., McFadden, T. B. & Forsyth, I. Hormonal regulation of mammary differentiation and milk secretion. J. Mammary Gland. Biol. Neoplasia 7, 49–66 (2002).
Monks, J., Ladinsky, M. S. & McManaman, J. L. Organellar contacts of milk lipid droplets. Contact 3, https://doi.org/10.1177/2515256419897226 (2020).
Sasaki, M., Eigel, W. N. & Keenan, T. W. Lactose and major milk proteins are present in secretory vesicle-rich fractions from lactating mammary gland. Proc. Natl Acad. Sci. USA 75, 5020–5024 (1978).
Acosta, J. J. et al. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol. Endocrinol. 17, 2268–2282 (2003).
Chen, C. C. et al. Akt is required for Stat5 activation and mammary differentiation. Breast Cancer Res. 12, R72 (2010).
Gore, A. C. et al. EDC-2: The Endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 36, E1–150 (2015).
The support of the Family Larsson-Rosenquist Foundation (to F.M.H. and S.H.K.) is gratefully acknowledged. R.V.T. has received a Wellcome Trust Investigator Award (grant number 106995/Z/15/Z); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme, and NIHR Senior Investigator Award (grant number NF- SI-0514–10091). L.N.V. has received a National Institutes of Health (NIH) grant (grant number U01ES026140). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
L.N.V. has been reimbursed for travel expenses by numerous organizations, including SweTox, Israel Environment Fund, the Mexican Endocrine Society, Advancing Green Chemistry, ShiftCon, US EPA, CropLife America, BeautyCounter, and many universities, to speak about endocrine-disrupting chemicals. L.N.V. also serves as a paid scientific adviser to SUDOC, LLC. S.H.K. holds a grant from the Family Larsson-Rosenquist Foundation to help the global dissemination of the INTERGROWTH-21st Preterm Postnatal Growth Standards and feeding recommendations, which include the use of human milk. The other authors declare no competing interests.
Peer review information
Nature Reviews Endocrinology thanks Margaret Neville and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Mammary rudiment
Small mammary ductal tree that develops in utero.
- Secretory differentiation
Alveolar luminal cells begin to synthesize milk components and accumulate cytoplasmic lipid droplets.
- Secretory activation
The initiation of copious milk secretion.
The continued synthesis and secretion of milk.
Initial mammary secretions produced after childbirth that are rich in immunological components.
Absence of lactation postpartum.
(TCDD). A persistent organic pollutant and toxic compound produced during the synthesis of chlorophenol and chlorophenoxy acid herbicides.
About this article
Cite this article
Hannan, F.M., Elajnaf, T., Vandenberg, L.N. et al. Hormonal regulation of mammary gland development and lactation. Nat Rev Endocrinol 19, 46–61 (2023). https://doi.org/10.1038/s41574-022-00742-y